R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (157 aa) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human FGF basic/FGF2 (157 aa) Protein is derived from E. coli. The Recombinant Human FGF basic/FGF2 (157 aa) Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Supplied as a 0.2μm filtered solution in Tris-HCl and NaCl with BSA as a carrier protein.
• Gene ID (Entrez): 2247
• Molecular Weight (g/mol): 17.4 kDa
• Name: FGF basic 157 aa
• Quantity: 25 μg
• Source: E. coli-derived human FGF basic/FGF2/bFGF protein Gly132-Ser288
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Gene Alias: Basic fibroblast growth factor, basic fibroblast growth factor bFGF, bFGF, FGF2, FGF-2, FGFBprostatropin, fibroblast growth factor 2 (basic), HBGF-2, heparin-binding growth factor 2, Prostatropin
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.